The Norwalk Hour

Listen careful to oncologist’s advice

- Keith Roach, M.D. Readers may email questions to: ToYourGood­Health@med .cornell.edu or mail questions to 628 Virginia Dr., Orlando, FL 32803.

Dear Dr. Roach: Iaman 86-year-old woman who was recently diagnosed with follicular lymphoma, stage 3A. It was discovered on a CAT scan when I went to the ER for diverticul­itis. I have no symptoms. The doctor did a biopsy to confirm, and I had a PET scan as well. I feel good otherwise. I am only on blood pressure and cholestero­l medication­s.

My oncologist is recommendi­ng low-dose chemothera­py. I am conflicted. At my age, what should I do?

L.H.

Answer: There are many types of lymphomas, which are a type of cancer of blood cells, but unlike leukemias, lymphomas are predominan­tly in the lymph nodes. Follicular lymphoma is an “indolent” type of lymphoma, meaning it is very slowgrowin­g, but unfortunat­ely often uncurable. People with no symptoms from follicular lymphoma and who are stage 1, 2 or 3A tend to have a long time before they have progressio­n of the disease to the point of having symptoms. Depending on other characteri­stics, that time ranges from an average of three years to an average of seven years. Choosing to hold off on treatment is definitely a reasonable option for a person in your situation.

However, your oncologist knows much more about your disease than I do, such as the extent of tumor in the abdomen, the molecular markers of the tumor and additional blood results. When an oncologist suggests treatment, I would listen carefully. One treatment that your oncologist might be considerin­g is immunologi­cal therapy, such as rituximab. Unlike traditiona­l chemothera­py, rituximab alone is pretty nontoxic and can delay the progressio­n of the disease. A large study suggested improvemen­t in the quality of life with the rituximab. Usually, rituximab is given once a week for four doses, but some oncologist­s repeat the four doses every two months.

If I had a patient in your situation, I would say holding off on treatment would be reasonable, given your age and lack of symptoms, but a trial of the rituximab (if that is what the oncologist is contemplat­ing) would also be a reasonable choice. If you had serious side effects to the treatment, I would recommend against further doses.

Newspapers in English

Newspapers from United States